Details
Stereochemistry | ACHIRAL |
Molecular Formula | C22H30N2O2.ClH |
Molecular Weight | 390.947 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CC(C)NCCCCOC1=C2COCC2=C(CC3=CC=CC=C3)N=C1C
InChI
InChIKey=NDUAUQZNHSFJMY-UHFFFAOYSA-N
InChI=1S/C22H30N2O2.ClH/c1-16(2)23-11-7-8-12-26-22-17(3)24-21(19-14-25-15-20(19)22)13-18-9-5-4-6-10-18;/h4-6,9-10,16,23H,7-8,11-15H2,1-3H3;1H
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C22H30N2O2 |
Molecular Weight | 354.4858 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Barucainide, an IB anti-arrhythmic agent, was evaluated in patients with coronary artery disease. Its antiarrhythmic effect was studied in patients with markedly depressed left-ventricular function. Barucainide was in phase II clinical trials to treat the patients with arrhythmias but the development of the drug was discontinued.
Originator
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1294860
The pharmacokinetic behavior of the class Ib antiarrhythmic drug barucainide was investigated in a phase I study in a group of 6 healthy male volunteers after oral administration of an initial single dose of 20 mg and incremental doses between 30 and 70 mg barucainide hydrochloride.
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:12:34 GMT 2023
by
admin
on
Fri Dec 15 15:12:34 GMT 2023
|
Record UNII |
RFI1WXG626
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
301-208-7
Created by
admin on Fri Dec 15 15:12:34 GMT 2023 , Edited by admin on Fri Dec 15 15:12:34 GMT 2023
|
PRIMARY | |||
|
93982-17-3
Created by
admin on Fri Dec 15 15:12:34 GMT 2023 , Edited by admin on Fri Dec 15 15:12:34 GMT 2023
|
PRIMARY | |||
|
RFI1WXG626
Created by
admin on Fri Dec 15 15:12:34 GMT 2023 , Edited by admin on Fri Dec 15 15:12:34 GMT 2023
|
PRIMARY | |||
|
DTXSID40240120
Created by
admin on Fri Dec 15 15:12:34 GMT 2023 , Edited by admin on Fri Dec 15 15:12:34 GMT 2023
|
PRIMARY | |||
|
146794
Created by
admin on Fri Dec 15 15:12:34 GMT 2023 , Edited by admin on Fri Dec 15 15:12:34 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |